Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Emiko Petrosky(National Center for Injury Prevention and Control), Lauri E. Markowitz(Centers for Disease Control and Prevention), Harrell W. Chesson(Centers for Disease Control and Prevention), Elizabeth R. Unger(Centers for Disease Control and Prevention), C. Robinette Curtis, Joseph A. Bocchini(Louisiana State University Health Sciences Center New Orleans), Mona Saraiya(Merck & Co., Inc., Rahway, NJ, USA (United States)), Susan Hariri
PubMed
March 27, 2015
Cited by 1,061

Related Papers

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.8k
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|PsycEXTRA Dataset|2007|1.9k
Prevalence of HPV Infection Among Females in the United States
|JAMA|2007|1.6k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
|JAMA|2006|1k